# Vir Biotechnology, Inc.: Form 8-K, filed Jun 26, 2024

- Company: [Vir Biotechnology, Inc.](/companies/vir.md) (CIK 1706431)
- Form: 8-K
- Filed: 2024-06-26
- Accepted by EDGAR: Jun 26, 2024, 08:15 ET
- Period: 2024-06-26
- Accession: 0001193125-24-168554
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1706431/000119312524168554/d835539d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1706431/000119312524168554/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1706431/000119312524168554/d835539d8k.htm

Filed Jun 26, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-168554. Last ingested by Listed: Nov 6, 2026, 19:03 ET. No prices; not investment advice.